MannKind down premarket as Ad Comm prepares to discuss AFREZZA Shares of MannKind Corp. (MNKD) are down 4% on modest premarket volume. The Endocrinologic and Metabolic Drugs Advisory Committee reviews AFREZZA's NDA tomorrow.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.